BIOLASE Announces $1M Investment in Advanced Manufacturing Facility

BIOLASE, a MegaGen company and global leader in dental laser technology, announced a significant investment in its Corona, California manufacturing operations, underscoring the company's long-term commitment to production capacity, quality, supply stability and continued innovation in dental laser care.

The Corona construction project represents a nearly $1 million dollar investment in manufacturing infrastructure, including demolition and new construction for production-support spaces, cleanroom construction, laser room and fiber room improvements, product and material warehouse enhancements, wall finishing upgrades, and expanded employee spaces including cafeteria, changing room and lunchroom areas.

This significant investment in advanced equipment and manufacturing capabilities is intended not only to increase production capacity to meet growing demand, but also to support scalable operations and uphold BIOLASE's commitment to quality, reliability, and manufacturing excellence for years to come.

This significant investment in advanced equipment and manufacturing capabilities is intended not only to increase production capacity to meet growing demand, but also to support scalable operations and uphold BIOLASE's commitment to quality, reliability, and manufacturing excellence for years to come.

In addition to enhancing manufacturing capacity and operational efficiency, the investment supports a broader strategic vision following BIOLASE's integration into the MegaGen family. The initiative further strengthens the Corona facility's role as a hub for scientific innovation and advanced manufacturing, while expanding global access to BIOLASE laser technologies through MegaGen's international distribution network and clinical education infrastructure.